Regional differences in tissue volume and perfusion in brains of individuals with mild cognitive impairment (MCI) versus normal healthy age-matched controls (NC), and the differences between MCI-AD converters and stable MCI patients were investigated. MRI and SPECT scans were performed on 13 MCI (74+6 years) and 12 NC (75+4 years). Of the MCI patients, 10 were followed for up to three years and 4 subsequently converted to Alzheimer's disease (AD). Episodic memory function was assessed using tests of delayed recall for word lists and stories. The volume reductions and hypoperfusion were mainly confined to the medial temporal lobe (MTL) of MCI patients and associated with worse scores on memory tests. Perfusion in the corpus callosum and the gray matter of frontal, lateral temporal, parietal or occipital lobe was not significantly affected in MCI. The 4 MCI-AD converters had relatively low MTL structural volume and perfusion compared to their stable peers.
Petersen RCMild cognitive impairment: transition between aging and Alzheimer's disease . Neurologia. 2000;15:93-101.
2.
Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
3.
Visser PJ, Scheltens P., Verhey FR, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 1999;246:477-485.
4.
Krasuski JS, Alexander GE, Horwitz B., et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls) . Biol Psychiatry. 1998;43:60-68.
5.
Xu Y., Jack, CR Jr , O.'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760-1767.
6.
Jack CR, Petersen RC, Xu Y., et al. Medial temporal atrophy in MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49:786-794.
7.
Selkoe DJAlzheimer's disease is a synaptic failure. Science. 2002;298:789-791.
8.
Guillozet AL , Weintraub S., Mash DC, Mesulam MMNeurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol. 2003;60: 729-736.
9.
Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397-1403.
10.
Grundman M. , Sencakova D., Jack CR, et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci. 2002;19:23-27.
11.
Kantarci K. , Jack CRNeuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am. 2003;13:197-209.
12.
Grundman M. , Lack CR, Petersen RC, et al. Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci. 2003;20:241-248.
13.
El Fakhri G. , Kijewski MF, Johnson KA, et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol.2003;60: 1066-1072.
14.
Dubois B., Feldman HH, Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6: 734-746.
15.
Kubota T., Ushijima Y., Yamada K., et al. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy? Eur J Nucl Med Mol Imaging. 2005;32:414-421.
16.
Lee YC, Liu RS, Liao YC, et al. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. European Neurology. 2003;49:142-145.
17.
Tanaka M., Fukuyama H., Yamauchi H., et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimaging. 2002 ;12:112-118.
18.
Kitayama N. , Matsuda H., Ohnishi T., et al. Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun. 2001;22:473-477.
Kogure D., Matsuda H., Ohnishi T., et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000;41:1155-1162.
21.
Petersen RC , Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
22.
Morris JCClinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(suppl 1): 173-176.
23.
Wang H., Shu L., Xie J., et al. Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2004;18:163-170.
24.
Raz N., Dupuis JH, Briggs SD, et al. Differential effects of age and sex on the cerebellar hemispheres and the vermis: a prospective MR study. AJNR Am J Neuroradiol . 1998;19:65-71.
25.
Lemieux L., Liu RSN, Duncan JSHippocampal and cerebellar volumetry in serially acquired MRI volume scans . Magn Reson Imaging. 2000;18:1027-1033.
26.
Lehericy S. , Baulac M., Chiras J., et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol . 1994;15:929-937.
27.
Ray K., Wang H., Chu Y., et al. Apparent diffusion coefficient in regional gray matter and white matter structures involved in mild cognitive impairment. Radiology. 2006;241:197-205.
28.
Chang LTMethod for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
29.
Pickut BA, Dierckx RA, Dobbeleir A., et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res. 1999;90:103-112.
30.
Folstein MF , Folstein SE, McHugh PR`Mini-mental state`. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.1975;12: 189-198.
31.
Petersen RC , Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(suppl 1):65-69.
32.
Morris JC, Heyman A., Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology.1989;39: 1159-1165.
Almkvist O.Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl. 1996;165:63-71.
35.
Price JL, Morris JCTangles and plaques in nondemented aging and ``preclinical'' Alzheimer's disease . Ann Neurol. 1999;45:358-368.
36.
Delacourte A., David JP, Sergeant N., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999;52:1158-1165.
37.
Strange BA, Otten LJ, Josephs O., et al. Dissociable human perirhinal, hippocampal, and parahippocampal roles during verbal encoding. J Neurosci. 2002;22:523-528.
38.
Huang C., Wahlund LO, Almkvist O., et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage. 2003;19:1137-1144.
39.
Inoue K., Ito H., Goto R., et al. Apparent CBF decrease with normal aging due to partial volume effects: MRbased partial volume correction on CBF SPECT. Ann Nucl Med. 2005;19:283-290.
40.
Barnden LR, Behin-Ain S., Kwiatek R., et al. Age related preservation and loss in optimized brain SPECT. Nucl Med Commun.2005;26:497-503.
41.
de Leon MJ, McRae T., Rusinek H., et al. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab. 1997;82:3251-3259.
42.
De Santi S. , de Leon MJ, Rusinek H., et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 2001;22:529-539.
43.
de Leon MJ, Convit A., Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A. 2001;98:10966-10971.
44.
Nestor PJ, Fryer TD, Smielewski P., Hodges JRLimbic hypometabolism in Alzheimer's disease and mild cognitive impairment . Ann Neurol. 2003;54:343-351.
45.
Hickie IB, Naismith SL, Ward PB, et al. Psychomotor slowing in older patients with major depression: relationships with blood flow in the caudate nucleus and white matter lesions . Psychiatry Res. 2007;155:211-220.
46.
Trollor JN, Sachdev PS, Haindl W., et al. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography. Psychiatry Clin Neurosci. 2005;59:280-290.
47.
Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JMMethods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol. 1995;16:637-643.
